Q2 FY26: standalone loss on impairment, consolidated PAT up 30%

Revenue Growth 20pctPat Growth 25pctExceptional ItemResults View source PDF Explain this filing

EIDPARRY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹1025.50

prior close

₹1015.50

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-0.8% vs market

Other Food Products peers, median of 24sector+0.5%-1.4% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 1.4 pts less than its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+1.2

15m

+0.8

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-0.1-0.8+0.5-1.4

Next day

+1.9+0.6+1.3+0.0+1.9

+1.7+0.2+1.5-0.3+2.0

+0.3+0.4-0.0-1.6+2.0

+2.4+1.0+1.3-2.4+4.8

+0.4+0.0+0.4-3.0+3.4

+0.2-0.5+0.7-4.7+4.9

15d

+1.3-1.9+3.2-7.3+8.6

+0.0-4.5+4.5-7.6+7.6

-8.8-5.4-3.4-11.6+2.8

-9.8-3.8-6.0-12.9+3.1

UpDownMarket · Nifty Smallcap 250Sector · Other Food Products peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

EID Parry's Q2 FY26 standalone results show a Rs 286 cr loss driven by Rs 352 cr impairment of investment in subsidiary PSRIPL. Consolidated revenue grew 25% YoY to Rs 11,624 cr; PAT rose about 30% to Rs 766 cr. H1 consolidated revenue up 27% to Rs 20,348 cr with PAT up around 50% at Rs 1,231 cr, driven by Coromandel's nutrient and crop protection businesses. Results carry unqualified limited review from Price Waterhouse.

Likely market impact

Standalone hit by one-time subsidiary impairment but consolidated business shows strong growth, driven by Coromandel's nutrient and crop protection segments.